Related Experiment Video
Updated: Mar 28, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Operational Changes in a Shared Resource Laboratory with the Use of a Product Lifecycle Management Approach: A Case
Philip Hexley1, Victoria Smith1, Samantha Wall1
1Office of the Vice Chancellor for Research, University of Nebraska Medical Center, Omaha, Nebraska 68198-5816, USA.
Abstract:
Shared Resource Laboratories (SRLs) provide investigators access to necessary scientific and resource expertise to leverage complex technologies fully for advancing high-quality biomedical research in a cost-effective manner. At the University of Nebraska Medical Center, the Flow Cytometry Research Facility (FCRF) offered access to exceptional technology, but the methods of operation were outdated and unsustainable. Whereas technology has advanced and the institute has expanded, the operations at the facility remained unchanged for 35 yr. To rectify this, at the end of 2013, we took a product lifecycle management approach to affect large operational changes and align the services offered with the SRL goal of education, as well as to provide service to researchers. These disruptive operational changes took over 10 mo to complete and allowed for independent end-user acquisition of flow cytometry data. The results have been monitored for the past 12 mo. The operational changes have had a positive impact on the quality of research, increased investigator-facility interaction, reduced stress of facility staff, and increased overall use of the resources. This product lifecycle management approach to facility operations allowed us to conceive of, design, implement, and monitor effectively the changes at the FCRF. This approach should be considered by SRL management when faced with the need for operationally disruptive measures.
Related Concept Videos
Scale-Up Processes
Bioreactor Design and Operational System
Upstream Processing
Methods of Medium Optimization
Drug Product Stability

